247 filings
8-K
ALBT
Avalon GloboCare Corp
27 Mar 24
Entry into a Material Definitive Agreement
4:10pm
SC 13D/A
Lu Wenzhao
24 Jan 24
Avalon GloboCare / Lu Wenzhao ownership change
8:35pm
8-K
ALBT
Avalon GloboCare Corp
22 Nov 23
Entry into a Material Definitive Agreement
4:49pm
10-Q
2023 Q3
ALBT
Avalon GloboCare Corp
Quarterly report
14 Nov 23
4:30pm
8-K
ALBT
Avalon GloboCare Corp
9 Nov 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
D
tlouzzsx5u79n0 73ahi
20 Oct 23
$700.00 k in Convertible Debt, sold $700.00 k, 2 investors
4:18pm
8-K
mwzk8u09rp
13 Oct 23
Entry into a Material Definitive Agreement
4:30pm
8-K
culkk2r6dgi i7owxu8
13 Oct 23
Departure of Directors or Certain Officers
9:15am
ARS
3doofqlf
8 Sep 23
Annual report to shareholders
5:21pm
8-K
w2w24ut9 8iak5
5 Sep 23
Patent for Multiple Novel QTY-Code Modified Cytokine and Chemokine Protein Receptor Molecules
8:56am
PRE 14A
cj3jv
29 Aug 23
Preliminary proxy
4:55pm
8-K
enj6cjh9fsb15exw2u
21 Aug 23
Avalon’s Laboratory Services MSO Announces Expansion into Arizona
9:11am
8-K
a0zpt 0p6
24 Jul 23
Avalon’s Laboratory Services MSO Acquires Texas Lab with Significant Potential Growth
9:05am
8-K
4jwljwcupxg5
19 Jul 23
Regulation FD Disclosure
9:21am
8-K
2o5gen
7 Jul 23
Entry into a Material Definitive Agreement
5:49pm
424B3
bw4o1 z3lj
29 Jun 23
Prospectus supplement
4:31pm
EFFECT
porqjfm 6r45vzwfep
29 Jun 23
Notice of effectiveness
12:15am
CORRESP
m6mbvqzb9swc1n4n
27 Jun 23
Correspondence with SEC
12:00am